Acceleron Pharma files to sell $100M in common stock Citigroup and Leerink Partners LLC are acting as joint book-running managers for the offering. Piper Jaffray & Co. is acting as lead manager and JMP Securities is acting as co-manager for the offering.
News For XLRN From The Last 14 Days
Check below for free stories on XLRN the last two weeks.
Piper Jaffray tech and biopharma analysts hold analyst/industry conference call Technical Analyst Johnson, along with BioPharma Analysts, discuss the recent downturn in the biotech and specialty pharmaceuticals industries on an Analyst/Industry conference call to be held on April 17 at 10 am.